×
We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Alna Trading & Exports Ltd., | NA | NA | NA | NA | 0 | |
| Oseaspre Consultants Ltd., | NA | NA | NA | NA | 0 | |
| NORRIS MEDICINES LTD. | NA | NA | NA | NA | 18.0 | |
| Integrated Capital Services Lt | NA | NA | NA | NA | 17.9 | 179.0 |
| Getalong Enterprise Limited | NA | NA | NA | NA | 17.5 | 125.0 |
Norris Medicines Ltd., with Security Code 524414, is a leading player in the Trading & Distributors industry, categorized under the Services sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.0 | 3.2 | 1.2 | 0.9 | 2.6 | 0.6 | 1.5 | 0.7 | 1.1 | 2.7 |
| Expenses | 2.8 | 2.8 | 0.7 | 1.3 | 2.8 | 0.7 | 1.0 | 0.9 | 1.1 | 2.6 |
| Operating Profit | 0.2 | 0.3 | 0.5 | -0.4 | -0.2 | 0.0 | 0.5 | -0.2 | 0.0 | 0.1 |
| OPM % | 7.79% | 10.59% | 44.93% | -40.8% | -9.63% | -6.19% | 32.73% | -22.21% | -2.44% | 3.9% |
| Other Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.6 | 0.4 | 0.4 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | -0.6 | -0.2 | 0.0 | -0.6 | -0.5 | -0.3 | 0.3 | -0.4 | -0.3 | -0.1 |
| Tax % | 0% | 0% | -4276.9% | 0% | 0% | 0% | -33.7% | 0% | 0% | 0% |
| Net Profit | -0.6 | -0.2 | -0.5 | -0.6 | -0.5 | -0.3 | 0.2 | -0.4 | -0.3 | -0.2 |
| EPS in Rs | -0.56 | -0.2 | -0.54 | -0.61 | -0.48 | -0.27 | 0.17 | -0.37 | -0.28 | 0 |
| Metrics | Sep 2024 |
|---|---|
| Sales | 1.3 |
| Expenses | 1.4 |
| Operating Profit | -0.1 |
| OPM % | -11.44% |
| Other Income | 0.0 |
| Interest | 0.1 |
| Depreciation | 0.1 |
| Profit before tax | -0.4 |
| Tax % | 0% |
| Net Profit | -0.4 |
| EPS in Rs | -0.36 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -12% |
| 5 Years: | -19% |
| 3 Years: | -23% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 5% |
| 3 Years: | 21% |
| TTM: | 56% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 51% |
| 3 Years: | -1% |
| 1 Year: | 52% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 0% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| News Date ▲▼ | Headline ▲▼ | Issuer Entity ▲▼ | Issuer Type ▲▼ | Order Size ▲▼ | Time Period ▲▼ | |
|---|---|---|---|---|---|---|
| Loading company updates… | ||||||
We couldn’t find any filings or updates in the Company News collection for this BSE code.
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|